International Companies

Sanofi to sell 50% stake in Opella to CD&R

By Michele Maatouk

Date: Monday 21 Oct 2024

(Sharecast News) - Sanofi said on Monday that it has agreed to sell a 50% stake in its consumer healthcare business, Opella, to US private equity firm Clayton, Dubilier & Rice in a €16bn deal.
Opella is behind brands such as Allegra, Doliprane and Dulcolax, and is already the third-largest business...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page